BCTXZ · BriaCell Therapeutics Corp. · Documents
$0.14
+0.01 (+10.66%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company's ability to continue as a going concern is dependent upon its ability to attain future profitable operations and to continue to obtain the necessary financing to meet its obligations arising from normal business operations when they come due. The uncertainty of the Company's ability to raise such financial capital casts substantial doubt on the Company's ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$30.97M
Shares
8.70M
Volume · Oct 27
10.29K
Avg daily vol (3M)
59.81K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| F-1/A | — | 2021-02-18 | — | |
| F-1/A | — | 2021-02-03 | — | |
| F-1/A | — | 2021-01-15 | — | |
| F-1/A | — | 2020-12-23 | — | |
| F-1/A | — | 2020-12-10 | — | |
| F-1/A | — | 2020-10-20 | — | |
| F-1/A | — | 2020-09-18 | — | |
| F-1/A | — | 2020-05-27 | — | |
| F-1/A | — | 2020-05-18 | — | |
| F-1/A | — | 2020-03-13 | — | |
| F-1/A | — | 2020-02-21 | — | |
| F-1/A | — | 2020-01-23 | — | |
| F-1/A | — | 2020-01-21 | — |
Showing 151–163 of 163 filings